Skip to content

Nirogacestat

Published: July 26, 2026Updated: July 26, 2026

Nirogacestat is a gamma-secretase inhibitor used in cancer treatment that works by blocking the proteolytic activation of the Notch receptor. By inhibiting Notch signaling, it prevents the activation of pathways that contribute to tumor growth when this receptor is dysregulated. It is classified as an antineoplastic (ATC-L01) agent.

Quick summary

Nirogacestat is an anticancer drug that inhibits gamma-secretase to block Notch signaling and prevent tumor growth.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
L01XX81
RxNorm
2670631
Generic
Nirogacestat
Class
atc-l01
Brands
Ogsiveo
Availability
rx
Lactation
unknown
Routes
oral
Forms
tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Nirogacestat is used to treat conditions associated with dysregulated Notch signaling, including desmoid tumors (aggressive fibromatosis). It is prescribed as an antineoplastic therapy for patients with progressive, unresectable tumors where Notch pathway activation contributes to disease progression.

Nirogacestat inhibits gamma-secretase, an enzyme responsible for the proteolytic activation of Notch receptors. By blocking this activation, the drug prevents Notch-mediated signaling cascades that drive tumor cell proliferation and survival. This targeted approach helps control tumor growth in cancers driven by Notch dysregulation.

As a targeted therapy, nirogacestat may cause side effects related to Notch inhibition. Patients should be monitored for gastrointestinal effects, fatigue, and other adverse reactions. Treatment should be supervised by an oncologist experienced with gamma-secretase inhibitors.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy